Impact of Sacubitril/Valsartan on Health-Related Quality of Life in Heart Failure-Preserved Ejection Fraction Patients

被引：0
|
作者：
Lewis, Eldrin F. [1 ]
Linssen, Gerard C. [2 ]
Tuvia, Ben Gal [3 ]
Vinereanu, Dragos [4 ]
Sweitzer, Nancy K. [5 ]
Saito, Yoshihiko [6 ]
Rizkala, Adel R. [7 ]
Solomon, Scott D. [8 ]
McMurray, John J. [9 ]
Zannad, Faiez [10 ]
机构：
[1] Brigham Womens Hosp, Div Cardiovasc Med, Boston, MA USA
[2] Hosp Grp Twente, Almelo, Netherlands
[3] Rabin Med Ctr Beilinson Campus, Dept Cardiol, Tel Aviv, Israel
[4] Univ Carol Davila, Bucharest, Romania
[5] Univ Arizona, Tucson, AZ USA
[6] Nara Med Univ, Kashihara, Nara, Japan
[7] Novartis Pharmaceut, E Hanover, NJ USA
[8] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[9] BHF Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[10] INSERM, CIC, Vandoeuvre Les Nancy, France
来源：
CIRCULATION | 2019年 / 140卷 / 25期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20970
引用
收藏
页码：E996 / E996
页数：1
相关论文
共 50 条
  • [1] Clinical factors associated with health-related quality of life in heart failure-preserved ejection fraction: a PARAMOUNT study
    Lewis, E. F.
    Guan, H.
    Zile, M.
    Packer, M.
    Pieske, B.
    Voors, A. A.
    Lefkowitz, M.
    Deschaseaux, C.
    Kulich, K.
    Solomon, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S111 - S111
  • [2] Effect on the Quality of Life of Patients with Heart Failure and Reduced/Preserved Ejection Fraction Using Sacubitril/Valsartan
    Huang, Yuanrui
    Wu, Xu
    Li, Xingyu
    Liu, Zhengzhong
    Li, Yunyi
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2023, 120 (08)
  • [3] Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    Butt, Jawad H.
    Dewan, Pooja
    Jhund, Pardeep S.
    Anand, Inder S.
    Atar, Dan
    Ge, Junbo
    Desai, Akshay S.
    Echeverria, Luis E.
    Kober, Lars
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Rouleau, Jean L.
    Sim, David
    Van Veldhuisen, Dirk J.
    Vrtovec, Bojan
    Zannad, Faiez
    Zile, Michael R.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Solomon, Scott D.
    McMurray, John J., V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : 1130 - 1143
  • [4] REPLY: Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction
    Chandra, Alvin
    Vaduganathan, Muthiah
    Lewis, Eldrin F.
    Claggett, Brian
    McMurray, John J. V.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2020, 8 (03) : 245 - 246
  • [5] Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction
    Tai, Andrew
    Ambrosy, Andrew P.
    Fudim, Marat
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E5 - E6
  • [6] Health-related quality of life among congestive heart failure patients with preserved and reduced ejection fraction
    Dian Hudiyawati
    Kartinah
    Afidatul Mujannidah
    FrontiersofNursing, 2024, 11 (01) : 111 - 117
  • [7] Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction
    Foa, Alberto
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Pabon, Maria A.
    Lu, Henri
    Pfeffer, Marc A.
    Packer, Milton
    Vardeny, Orly
    Rouleau, Jean L.
    Lefkowitz, Martin
    Mentz, Robert J.
    Jhund, Pardeep S.
    Desai, Akshay S.
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (18) : 1731 - 1739
  • [8] Sacubitril/valsartan in an experimental model of heart failure with preserved ejection fraction
    De Angelis, A.
    Cappetta, D.
    Telesca, M.
    Bellocchio, G.
    Urbanek, K.
    Berrino, L.
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPPL 1)
  • [9] Impact of Sacubitril/ Valsartan on quality of life and ejection fraction of heart failure patients with and without chronic kidney disease
    Zartash, Syeda Huma
    Saleem, Sidra
    Mansur, Abeera
    Rasool, Zain
    Sheikh, Shahryar Ahmad
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (06) : 1049 - 1053
  • [10] Sacubitril/valsartan as a Treatment for Resistant Hypertension in Patients With Heart Failure and Preserved Ejection Fraction
    Jhund, Pardeep S.
    Alice, M.
    Pfeffer, Marc A.
    Zannad, Faiez
    Lefkowitz, Martin P.
    Shi, Victor
    Vardeny, Orly
    Solomon, Scott
    McMurray, John J.
    CIRCULATION, 2020, 142
12345